StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Analysts at StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Monday. The firm set a “hold” rating on the stock.

ObsEva Stock Performance

The firm has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The business’s 50 day moving average price is $0.01. ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.